Long-Term Effects of Risperidone in Children With Autism Spectrum Disorders: A Placebo Discontinuation Study
- 1 November 2005
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 44 (11), 1137-1144
- https://doi.org/10.1097/01.chi.0000177055.11229.76
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Weight and Leptin Changes Among Risperidone-Treated Youths With Autism: 6-Month Prospective DataAmerican Journal of Psychiatry, 2004
- Long-Term, Open-Label Study of Risperidone in Children With Severe Disruptive Behaviors and Below-Average IQAmerican Journal of Psychiatry, 2004
- Risperidone Treatment of Children with Autistic Disorder: Effectiveness, Tolerability, and Pharmacokinetic ImplicationsJournal of Child and Adolescent Psychopharmacology, 2004
- Adverse Metabolic Effects Associated with Atypical AntipsychoticsDrugs, 2004
- Weight Gain Associated with Atypical Antipsychotic Use in Children and AdolescentsPediatric Drugs, 2004
- Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with AutismJournal of Child and Adolescent Psychopharmacology, 2001
- Bodyweight Gain Associated with Atypical AntipsychoticsCNS Drugs, 2001
- Atypical neuroleptics in child and adolescent psychiatryEuropean Child & Adolescent Psychiatry, 2000
- Use of Risperidone in Pervasive Developmental Disorders: A Case SeriesJournal of Child and Adolescent Psychopharmacology, 1996
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970